The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
VA Office of Research and Development
Tizona Therapeutics, Inc
Essen Biotech
IDEAYA Biosciences
Weill Medical College of Cornell University
University of Kentucky
University of California, San Francisco